Ionis Pharmaceuticals (IONS) Interest Coverage Ratio (2009 - 2026)
Ionis Pharmaceuticals (IONS) recorded quarterly Interest Coverage Ratio of 22.76 in Q1 2026, up 48.77% quarter-over-quarter from 44.42 in Q4 2025, and up 36.34% on a YoY basis from 16.69 in Q1 2025.
Ionis Pharmaceuticals (IONS) Interest Coverage Ratio (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Interest Coverage Ratio history runs 18 years deep, the most recent figure standing at 22.76 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 36.34% year-over-year to 22.76; the TTM figure through Mar 2026 stood at 19.23 (up 30.99% YoY), while the FY2025 annual figure was 4.62, up 18.77% from the prior year.
- Interest Coverage Ratio was 22.76 for Q1 2026 at Ionis Pharmaceuticals, up from 44.42 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 33.99 in Q2 2025 to a low of 120.17 in Q4 2022.
- Historically, Interest Coverage Ratio has averaged 34.16 across 5 years, with a median of 35.73 in 2024.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio sank 1868.73% in 2024, then soared 330.89% in 2025.
- A 5-year view of Interest Coverage Ratio shows it stood at 120.17 in 2022, then jumped by 98.88% to 1.34 in 2023, then tumbled by 1868.73% to 26.44 in 2024, then sank by 67.99% to 44.42 in 2025, then jumped by 48.77% to 22.76 in 2026.
- The last three Interest Coverage Ratio figures came in at 22.76 (Q1 2026), 44.42 (Q4 2025), and 38.03 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Ionis Pharmaceuticals | 12.23 Bn | 10.31 Bn | 243.11 Mn | -22.76 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.76 |
| Dec 31, 2025 | -44.42 |
| Sep 30, 2025 | -38.03 |
| Jun 30, 2025 | 33.99 |
| Mar 31, 2025 | -35.75 |
| Dec 31, 2024 | -26.44 |
| Sep 30, 2024 | -35.73 |
| Jun 30, 2024 | -14.72 |
| Mar 31, 2024 | -36.02 |
| Dec 31, 2023 | -1.34 |
| Sep 30, 2023 | -34.09 |
| Jun 30, 2023 | -39.37 |
| Mar 31, 2023 | -70.99 |
| Dec 31, 2022 | -120.17 |
| Sep 30, 2022 | -27.65 |
| Jun 30, 2022 | -40.15 |
| Mar 31, 2022 | -27.10 |
| Dec 31, 2021 | 98.57 |
| Sep 30, 2021 | -36.69 |
| Jun 30, 2021 | -30.96 |